Avantor Inc (NYSE:AVTRpA.PFD)
$ 90.81 0 (0%) Market Cap: - Enterprise Value: - PE Ratio: 50.60 PB Ratio: 2.79 GF Score: 76/100

Avantor Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2022 / 08:15PM GMT
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

All right. Good afternoon, everyone. My name is Tejas Savant, and I'm the life science tools and diagnostics analyst at Morgan Stanley. It's my pleasure to host Avantor this afternoon. And with me is Michael Stubblefield. In the audience, we have Tom Szlosek, and CJ is out there somewhere as well. So welcome, guys, and thanks for doing this.

Before we get started, just a quick disclaimer that I need to read off over here. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, do reach out to your Morgan Stanley sales rep.

Questions & Answers

Tejas Rajeev Savant;Michael Stubblefield
Morgan Stanley, Research Division - Equity Analyst;Avantor, Inc.

So with that, Michael, it's been a very dynamic year for Avantor with a lot of moving pieces. So as you sit here today, what are some of your reflections on the business performance year-to-date?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot